Wed, Apr 16, 2014, 3:09 AM EDT - U.S. Markets open in 6 hrs 21 mins

Recent

% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

outboard.jack 281 posts  |  Last Activity: 5 hours ago Member since: Nov 26, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • outboard.jack outboard.jack 5 hours ago Flag

    Two kids woke up right after XMas morning...one found a bike by his door ribbon and all...and he said, 'Oh I dont know how to ride. I might fall and get hurt.' the other got nothing but a pile of manure by the front of his house, 'Hey I think my new horse is around here somewhere.' A happy life is the the way you see things in life...think positive and you shall find success.

    If you know what's coming you know how to play it.*

  • outboard.jack by outboard.jack 17 hours ago Flag

    Look at historical prices ( 2 years Pryor ) to Nov 2012 ADCOM with NO Product

    Closing Prices

    Dec 28, 2010 3.05
    Dec 27, 2010 3.04
    Dec 23, 2010 2.98
    Dec 22, 2010 3.06
    Dec 21, 2010 3.06
    Dec 20, 2010 3.00
    Dec 17, 2010 2.73
    Dec 16, 2010 2.60
    Dec 15, 2010 2.49
    Dec 14, 2010 2.55
    Dec 13, 2010 2.44
    Dec 10, 2010 2.30
    Dec 9, 2010. 2.31
    Dec 8, 2010 2.17
    Dec 7, 2010. 2.11
    Dec 6, 2010. 2.01
    Dec 3, 2010. 1.99
    Dec 2, 2010. 2.04
    Dec 1, 2010. 2.03
    Nov 30, 2010 2.00
    Nov 29, 2010 2.06
    Nov 26, 2010 2.14
    Nov 24, 2010 2.02
    Nov 23, 2010 1.92
    Nov 22, 2010 2.01
    Nov 19, 2010 1.95
    Nov 18, 2010 1.97
    Nov 17, 2010. 1.90
    Nov 16, 2010 1.98
    Nov 15, 2010 2.06 Less

  • Reply to

    On Day 15 the SUN came up

    by outboard.jack 20 hours ago
    outboard.jack outboard.jack 17 hours ago Flag

    Good to hear from you Rave,
    I must admit I was very disappointed with the delay of the news we received today, But in DINO TYPE Fashion our new CEO has shown his true colors. I'm not sure what detail constitutes the start of the program but none the less here we are, could have been worse.
    GL2Y * and God save the Queen

  • BERKELEY, CA--(Marketwired - Apr 15, 2014) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced initiation of a new phase 3 clinical trial of HEPLISAV-B, its investigational adult hepatitis B vaccine. This large safety and immunogenicity study (known as HBV-23) was designed to address the Complete Response Letter regarding the HEPLISAV-B Biologics License Application that was issued to Dynavax by the U.S. Food and Drug Administration in February, 2013.

    HBV-23 will provide greater clarity regarding the safety profile of HEPLISAV-B by significantly expanding the overall database of vaccinated subjects. The study will also assess the immunogenicity of HEPLISAV-B in subjects for whom approved hepatitis B vaccines are less effective. Dynavax expects that all study subjects will be enrolled by the end of 2014 and all follow-up will be completed by the fourth quarter of 2015.

    HBV-23 Study Design

    HBV-23 is an observer-blinded, randomized, active-controlled, trial being conducted at approximately 40 sites in the U.S. Approximately 8,250 adult subjects between the ages of 18 and 70 will be randomized in a 2:1 ratio to receive a 2-dose series of HEPLISAV-B or a 3-dose series of a control vaccine, Engerix-B®. Enrollment will be stratified by site, age group and type 2 diabetes mellitus status. Safety follow-up will continue for all subjects through study week 56.

    The co-primary objectives of HBV-23 are to:

    Evaluate the overall safety of HEPLISAV-B with respect to clinically significant adverse events (AEs), and
    Demonstrate the noninferiority of the seroprotection rate induced by HEPLISAV-B compared with Engerix-B at Week 28 in subjects with type 2 diabetes mellitus.
    The study also includes multiple secondary objectives intended to further elucidate the safety profile of HEPLISAV-B with respect to specific outcomes and to assess its immunogenicity in subpopulations including smokers, men, individuals with higher body mass, and those aged 40 years and older

  • Reply to

    Grey Delay

    by outboard.jack Apr 3, 2014 2:40 PM
    outboard.jack outboard.jack Apr 14, 2014 5:55 PM Flag

    Day 14

  • Reply to

    Bad news coming...

    by greenstockers Apr 14, 2014 2:06 PM
    outboard.jack outboard.jack Apr 14, 2014 2:22 PM Flag

    Gonna be 10 Million dollars plus spent today Telling you to COVER*

  • Reply to

    NO TRIALS FOR 3 MONTHS. COMPANY WEB SITE.

    by greenstockers Apr 14, 2014 10:35 AM
    outboard.jack outboard.jack Apr 14, 2014 2:13 PM Flag

    TYPO for you*

  • Reply to

    NO TRIALS FOR 3 MONTHS. COMPANY WEB SITE.

    by greenstockers Apr 14, 2014 10:35 AM
    outboard.jack outboard.jack Apr 14, 2014 2:12 PM Flag

    Yea, SEC comming

  • outboard.jack by outboard.jack Apr 14, 2014 12:40 PM Flag

    Gonna run out of Kids willing to give it up*

  • Reply to

    NO TRIALS FOR 3 MONTHS. COMPANY WEB SITE.

    by greenstockers Apr 14, 2014 10:35 AM
    outboard.jack outboard.jack Apr 14, 2014 11:02 AM Flag

    I suggest you cover*

  • outboard.jack outboard.jack Apr 14, 2014 7:38 AM Flag

    Russians have Hep B
    Just saying

  • outboard.jack by outboard.jack Apr 13, 2014 2:11 PM Flag

     

    Look at historical prices ( 2 years Pryor ) to Nov 2012 ADCOM with NO Product !

    Closing Prices 

    Dec 28, 2010 3.05
    Dec 27, 2010 3.04
    Dec 23, 2010 2.98
    Dec 22, 2010 3.06
    Dec 21, 2010 3.06
    Dec 20, 2010 3.00
    Dec 17, 2010 2.73
    Dec 16, 2010 2.60
    Dec 15, 2010 2.49
    Dec 14, 2010 2.55
    Dec 13, 2010 2.44
    Dec 10, 2010 2.30
    Dec 9, 2010. 2.31
    Dec 8, 2010 2.17
    Dec 7, 2010. 2.11
    Dec 6, 2010. 2.01
    Dec 3, 2010. 1.99
    Dec 2, 2010. 2.04
    Dec 1, 2010. 2.03
    Nov 30, 2010 2.00
    Nov 29, 2010 2.06
    Nov 26, 2010 2.14
    Nov 24, 2010 2.02
    Nov 23, 2010 1.92
    Nov 22, 2010 2.01
    Nov 19, 2010 1.95
    Nov 18, 2010 1.97
    Nov 17, 2010.   1.90
    Nov 16, 2010 1.98
    Nov 15, 2010 2.06

  • outboard.jack by outboard.jack Apr 10, 2014 9:29 AM Flag

    LYON, France, April 10, 2014 (GLOBE NEWSWIRE) -- EDAP, the global leader in therapeutic ultrasound, announced its participation at the European Association of Urology (EAU) 2014 Annual Congress that will be held in Stockholm on April 11-15, 2014. EDAP's HIFU and lithotripsy device portfolio will be featured in multiple poster sessions.

    John Rewcastle, Ph.D., Medical Director of EDAP TMS, commented, "The EAU is one of the leading global events in the field of urology. Clinical data that will be presented provides further recognition and validation of HIFU for the treatment of prostate cancer. Noteworthy is the interest generated among leading clinicians for our Focal One(R) device. The presentations to be made on Focal One showcase important milestones in the progression of this device that received the CE mark in June of last year."

    The scientific program will include seven poster abstracts pertaining to clinical research by clinicians and scientists utilizing Ablatherm HIFU and Focal One. EDAP's devices will be highlighted in three continuing education courses pertaining to prostate imaging, focal treatment of prostate cancer and an update on stone disease. The Company will host live demonstrations at its booth of both the Focal One and the Sonolith i-move devices. A meeting of the @-Registry users will be held to provide data and publication updates. The @-Registry is an approved global registry of HIFU data from patients with HIFU. This meeting will include discussions by significant luminaries within the European urology community who are also experienced practitioners of Ablatherm-HIFU.

    Marc Oczachowski, EDAP's Chief Executive Officer, said, "We are proud that posters highlighting our Ablatherm-HIFU and Focal One devices have been accepted for presentation at the upcoming EAU Annual Congress. This is clear academic recognition of HIFU as a valuable technology for treating prostate cancer and reflects positively on the high level of research

  • outboard.jack by outboard.jack Apr 9, 2014 4:09 PM Flag

    It's how they take your stuff

    3/31/2014
    30,405,093

    3/14/2014
    25,976,848

    2/28/2014
    24,879,799

    2/14/2014
    25,315,694

  • Reply to

    So they released news today....

    by swihart_art Apr 8, 2014 10:16 AM
    outboard.jack outboard.jack Apr 9, 2014 12:09 PM Flag

    When in Vegas I find the lowest limit Blackjack table in town wait till the slowest time of the day and play the dealer heads up with two slots and beat the house on a regular basis.

  • Reply to

    So they released news today....

    by swihart_art Apr 8, 2014 10:16 AM
    outboard.jack outboard.jack Apr 9, 2014 9:56 AM Flag

    Great buy op
    EZ money *

  • Reply to

    Grey Delay

    by outboard.jack Apr 3, 2014 2:40 PM
    outboard.jack outboard.jack Apr 6, 2014 6:53 PM Flag

    Very well said Tramp,
    Grey himself spoke of the time line. This is not a small staffed company and this is a third time for a phase three study. Leaves a lot to speculate about as to why there is a delay. I would think Grey would be on top of his own time line.

  • Reply to

    Grey Delay

    by outboard.jack Apr 3, 2014 2:40 PM
    outboard.jack outboard.jack Apr 6, 2014 3:11 PM Flag

    Day 6
    Expected better given the fact Co Had better than a Year to prepare

  • Reply to

    Have some Vishion / It's investing

    by outboard.jack Apr 4, 2014 7:43 AM
    outboard.jack outboard.jack Apr 4, 2014 7:44 AM Flag

    Vision

    O well*

  • The HIFU division believes that HIFU therapy could be expanded to other medical conditions, such as certain localized thyroid, breast, gynecological, bladder, kidney, liver, brain, pancreatic and retroperitoneal tumors. However, the expansion of the use of HIFU to other areas of treatment will require a significant investment in research and development, an investment we will undertake gradually while focusing on the acceptance of HIFU as a treatment for localized prostate cancer.

DVAX
1.45-0.05(-3.33%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.